Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinomaTaketo Kawai, Haruki Kume, Takehiro Tanaka et al.|Japanese Journal of Clinical Oncology|2025Cited by 7
The Roles of Tripartite Motif Proteins in Urological Cancers: A Systematic ReviewYuta Yamada, Haruki Kume, Naoki Kimura et al.|Cancers|2025Cited by 5
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched studySatoru Taguchi, Haruki Kume, Taketo Kawai et al.|International Journal of Clinical Oncology|2025Cited by 3
Novel clipping procedure for preventing post‐operative inguinal hernia in robot‐assisted radical prostatectomyYuji Hakozaki, Haruki Kume, Yuta Yamada et al.|International Journal of Urology|2024Cited by 2
Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration‐Resistant Prostate CancerTaketo Kawai, Haruki Kume, Kazuki Maki et al.|The Prostate|2025Cited by 1